Company intelligence / Profile preview

Cartana

Solna, Sweden

Ownership: Private
Employees: ~70
Development stage: Commercial

Overview

Cartana developed an innovative spatial sequencing technology enabling high-throughput mapping of gene expression in tissue samples while preserving tissue morphology. This allows researchers to analyze hundreds of genes simultaneously at single-cell resolution within intact tissues. The technology has been described as "Google Maps for finding how specific genes are expressed in the body"[1]. No clinical results as it does not develop therapeutics directly.

Therapeutic areas: OncologyImmunologyNeurology
Modalities: Spatial genomicsIn Situ Sequencing (ISS)
Industry: Molecular Diagnostics

Partnerships

Not specifically listed; collaborations with academic and industry researchers implied.

Beyond the preview

Go deeper on Cartana.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cartana.

Explore the full profile